Assignee
BASILEA PHARMACEUTICA AG
CH·47 granted patents·5 pending applications·179 citations·filing 1998–2018
Top patents by PatentIndex Score
52 records- 0194US6812238B1N-substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Nov 2, 2004·47 cites·19 claims
- 0287US6821980B1Substituted 5-benzyl-2,4-diaminopyrimidinesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Nov 23, 2004·30 cites·28 claims
- 0383US7459561B2N-substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2006·Granted Dec 2, 2008·3 cites·21 claims
- 0482US6504025B2Process for the preparation of vinyl-pyrrolidinone cephalosporin derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Jan 7, 2003·14 cites·16 claims
- 0581US9970938B2Use of BUBR1 as a biomarker of drug response to furazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2016·Granted May 15, 2018·2 cites·60 claims
- 0677US10067120B2Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2016·Granted Sep 4, 2018·2 cites·59 claims
- 0777US7524823B2MacrolidesBASILEA PHARMACEUTICA AG·Filed 2006·Granted Apr 28, 2009·5 cites·15 claims
- 0875US7816537B2Process for the manufacture of epoxybutanol intermediatesBASILEA PHARMACEUTICA AG·Filed 2006·Granted Oct 19, 2010·1 cites·17 claims
- 0973US8927542B2Bicyclic antibioticsBASILEA PHARMACEUTICA AG·Filed 2014·Granted Jan 6, 2015·2 cites·34 claims
- 1070US7423157B2Substituted benzimidazoles and their use for inducing apoptosisBASILEA PHARMACEUTICA AG·Filed 2006·Granted Sep 9, 2008·1 cites·6 claims
- 1170US7151182B2Intermediates for N-substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Dec 19, 2006·3 cites·10 claims
- 1269US6420166B2Process for the preparation of D-asparagine derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Jul 16, 2002·2 cites·8 claims
- 1368US6995143B2Macrolides with antibacterial activityBASILEA PHARMACEUTICA AG·Filed 2003·Granted Feb 7, 2006·3 cites·57 claims
- 1467US9511064B2Combination therapy for the treatment of cancer and immunosuppressionBASILEA PHARMACEUTICA AG·Filed 2013·Granted Dec 6, 2016·2 cites·25 claims
- 1567US8933073B2Macrolides and their useBASILEA PHARMACEUTICA AG·Filed 2014·Granted Jan 13, 2015·1 cites·25 claims
- 1667USRE42890EFurazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Nov 1, 2011·4 cites·39 claims
- 1767US6828442B2Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium saltsBASILEA PHARMACEUTICA AG·Filed 2001·Granted Dec 7, 2004·2 cites·2 claims
- 1867US6437142B1Process for preparing retiferol derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Aug 20, 2002·5 cites·4 claims
- 1965US7385061B2FurazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Jun 10, 2008·3 cites·17 claims
- 2064US9133219B2Bicyclic antibioticsBASILEA PHARMACEUTICA AG·Filed 2014·Granted Sep 15, 2015·0 cites·21 claims
- 2164US6384214B1Process for producing cephalosporin derivativesBASILEA PHARMACEUTICA AG·Filed 2000·Granted May 7, 2002·3 cites·18 claims
- 2263US7262307B21′-benzyl-3-bromo-[1,3′]bipyrrolidinyl-2-oneBASILEA PHARMACEUTICA AG·Filed 2004·Granted Aug 28, 2007·2 cites·1 claims
- 2361US10724072B2Use of phospho-Akt as a biomarker of drug responseBASILEA PHARMACEUTICA AG·Filed 2018·Granted Jul 28, 2020·0 cites·65 claims
- 2461US10656162B2Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2018·Granted May 19, 2020·0 cites·48 claims
- 2561US7189858B2N-phenyl substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Mar 13, 2007·1 cites·20 claims
- 2661US6589989B1Treatment of cell-mediated immune diseasesBASILEA PHARMACEUTICA AG·Filed 1998·Granted Jul 8, 2003·18 cites·8 claims
- 2761US6376491B1Bicyclic compoundsBASILEA PHARMACEUTICA AG·Filed 1999·Granted Apr 23, 2002·20 cites·44 claims
- 2860US9783508B2Process for the manufacture of isavuconazole or ravuconazoleBASILEA PHARMACEUTICA AG·Filed 2013·Granted Oct 10, 2017·1 cites·20 claims
- 2960US6849709B2Aerothricin derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Feb 1, 2005·1 cites·13 claims
- 3059US7951957B2Substituted benzimidazoles and their use for inducing apoptosisBASILEA PHARMACEUTICA AG·Filed 2008·Granted May 31, 2011·0 cites·25 claims
- 3156US9163034B2Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and useBASILEA PHARMACEUTICA AG·Filed 2014·Granted Oct 20, 2015·0 cites·11 claims
- 3254US9738676B2Selected macrolides with PDE4-inhibiting activityBASILEA PHARMACEUTICA AG·Filed 2013·Granted Aug 22, 2017·0 cites·11 claims
- 3354US9120822B2Tricyclic antibioticsBASILEA PHARMACEUTICA AG·Filed 2014·Granted Sep 1, 2015·0 cites·46 claims
- 3454US2005042278A1New formulation for retinoid-containing soft gelatin capsulesBASILEA PHARMACEUTICA AG·Filed 2004·Application pending·0 cites
- 3553US8809315B2Combination medicaments for treating bacterial infectionsBASILEA PHARMACEUTICA AG·Filed 2013·Granted Aug 19, 2014·0 cites·20 claims
- 3653US7531650B2Cephalosporin salts in crystalline formBASILEA PHARMACEUTICA AG·Filed 2004·Granted May 12, 2009·0 cites·6 claims
- 3751US10221206B2Selected macrolides with PDE4-inhibiting activityBASILEA PHARMACEUTICA AG·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 3851US9346799B2Useful combinations of monobactam antibiotics with beta-lactamase inhibitorsBASILEA PHARMACEUTICA AG·Filed 2014·Granted May 24, 2016·0 cites·5 claims
- 3950US2007167505A1Substituted benzimidazoles and their use for inducing apoptosisBASILEA PHARMACEUTICA AG·Filed 2005·Application pending·0 cites
- 4047US7064199B2Process for the manufacture of 3-amino-pyrrolidine derivativesBASILEA PHARMACEUTICA AG·Filed 2003·Granted Jun 20, 2006·0 cites·1 claims
- 4146US7115643B2Intermediate halophenyl derivatives and their use in a process for preparing azole derivativesBASILEA PHARMACEUTICA AG·Filed 2002·Granted Oct 3, 2006·0 cites·28 claims
- 4246US6403346B1Enzymatic processes for producing intermediates useful in the manufacture of retiferol derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Jun 11, 2002·0 cites·4 claims
- 4346US6310262B1Process for preparing retiferol derivativesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Oct 30, 2001·0 cites·5 claims
- 4446US2008032962A1Stabilized Freeze-Dried Formulation for Cephalosporin DerivativesBASILEA PHARMACEUTICA AG·Filed 2005·Application pending·0 cites
- 4545US10590092B2Process for the manufacture of isavuconazole or ravuconazoleBASILEA PHARMACEUTICA AG·Filed 2017·Granted Mar 17, 2020·0 cites·3 claims
- 4641US6818649B2Chromenylmethyl pyrimidinediamines as antibacterial agentsBASILEA PHARMACEUTICA AG·Filed 2001·Granted Nov 16, 2004·0 cites·11 claims
- 4741US6703397B2Pyrimidinyl methyl indole derivatives with antibacterial activityBASILEA PHARMACEUTICA AG·Filed 2001·Granted Mar 9, 2004·0 cites·14 claims
- 4841US2016122320A1Useful combinations of monobactam antibiotics with beta-lactamase inhibitorsBASILEA PHARMACEUTICA AG·Filed 2016·Application pending·0 cites
- 4940US6319933B1Azole derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Nov 20, 2001·0 cites·15 claims
- 5031US6489440B1Cyclic compoundsBASILEA PHARMACEUTICA AG·Filed 1999·Granted Dec 3, 2002·1 cites·51 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BASILEA PHARMACEUTICA AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →